Barr pharmaceuticals

Develops, manufacturers, and markets generic and proprietary pharmaceuticals in specific therapeutic categories. Includes consumer and investor data from Pomona, New York. (NYSE ...

Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc., (NYSE: BRL) is global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development ...

Barr Pharmaceuticals - Wikipedia, the free encyclopedia

Corporate History. Founded in 1970 in New York as Barr Laboratories, Inc., the Company was among the first generic pharmaceutical manufacturers in the U.S.

Barr Pharmaceuticals, Inc.

64.58 +$0.58 (Up 0.56%) Volume: 2,791,684 : Nov 21, 2008 Barr Shareholders Approve Pending Teva Acquisition... Nov 19, 2008 Barr Announces Agreements on Nasacort(R) AQ ...

Barr Pharmaceuticals, Inc.

This company has recently been acquired or received a credible acquisition offer. Barr Pharmaceuticals is the parent company for Barr...

Barr Pharmaceuticals (BRL)

Barr Pharmaceuticals, Inc. is a Delaware holding company whose principal subsidiaries, Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc., develop, manufacture and market ...

BRL - Barr Pharmaceuticals Inc Stock quote - CNNMoney.com

Get the latest on Barr Pharmaceuticals, Inc. (BRL) including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google Finance.

BRL - Barr Pharmaceuticals, Inc. - Google Finance

Barr Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of generic and proprietary pharmaceuticals. Its generic product portfolio includes solid oral ...

BRL: Summary for BARR PHARMA INC - Yahoo! Finance

Barr Pharmaceuticals Inc. 225 Summit Avenue Montvale, NJ 07645 United States - Map Phone: 201-930-3300 Fax: 201-930-3330 Web Site: http://www.barrlabs.com